Discovery of a Tunable Heterocyclic Electrophile 4-Chloro-pyrazolopyridine That Defines a Unique Subset of Ligandable Cysteines-Reference-Cited by-同舟云学术

Discovery of a Tunable Heterocyclic Electrophile 4-Chloro-pyrazolopyridine That Defines a Unique Subset of Ligandable Cysteines

Published:2024-04-17 Issue:5 Volume:19 Page:1082-1092
ISSN:1554-8929
Container-title:ACS Chemical Biology
language:en
Short-container-title:ACS Chem. Biol.

Author:

Kim Hong-Rae¹^ORCID,Byun David P.¹,Thakur Kalyani¹,Ritchie Jennifer¹,Xie Yixin¹,Holewinski Ronald²,Suazo Kiall F.²,Stevens Mckayla³,Liechty Hope³,Tagirasa Ravichandra¹,Jing Yihang¹,Andresson Thorkell²,Johnson Steven M.³^ORCID,Yoo Euna¹^ORCID

Affiliation:

1. Chemical Biology Laboratory, Center for Cancer Research, National Cancer Institute, Frederick, Maryland 21702, United States

2. Protein Characterization Laboratory, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Frederick, Maryland 21702, United States

3. Department of Biochemistry and Molecular Biology, Indiana University School of Medicine, Indianapolis, Indiana 46202, United States

Funder

National Cancer Institute

Publisher

American Chemical Society (ACS)

Link

https://pubs.acs.org/doi/pdf/10.1021/acschembio.4c00025

Reference63 articles.

1. Targeted Covalent Inhibitors for Drug Design

2. Covalent inhibitors in drug discovery: from accidental discoveries to avoided liabilities and designed therapies

3. Activity-based probes that target diverse cysteine protease families

4. The pharmacological landscape and therapeutic potential of serine hydrolases

5. Covalent Small Molecule Immunomodulators Targeting the Protease Active Site

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 4-Chloropyrazolopyridine as a Tunable, Covalently Acting SNAr Electrophile;Synfacts;2024-07-25